ProfCeline Marmion
Professor
Department of Chemistry
Orcid identifier0000-0003-0637-6693 (opens in a new tab)
- ProfessorDepartment of Chemistry
- 353 1 4022161 (Work)
- RCSI, Chemistry, 123 St Stephens Green, Dublin 2
RESEARCH OVERVIEW
Cancer is one of the most complex and deadly diseases known to man. Although today nearly 50% of all anti-cancer therapies are Pt-based, surprisingly to date only three Pt drugs have been approved for worldwide clinical use, namely cisplatin, carboplatin and oxaliplatin. The cytotoxicity of Pt drugs is attributed to their ability to bind DNA and induce apoptosis. There are drawbacks however associated with their use (such as their limited activity against many common human cancers, their susceptibility to acquired drug resistance and their toxicity) which limits their widespread application and efficacy. The search for metallodrugs (Pt or non-Pt based) which (i) target the cell and/or (ii) have a different mode of action to Pt drugs currently in clinical use remains the subject of intense investigation. We are currently exploring a number of different strategies with a view to developing metallodrugs with enhanced selectivity for the cell nucleus and, in so doing, advance a new class of chemotherapeutic beyond those currently in use.
GRANTS
- FUNDED PROJECTStEP Programme 2026-27RCSI1 Oct 2026 - 30 Sep 2027
- FUNDED PROJECTStudent Selected Projects (SSP) 2026RCSI9 Feb 2026 - 21 Dec 2026
- FUNDED PROJECTStEP Programme 2025-26RCSI30 Sep 2025 - 29 Sep 2027
- FUNDED PROJECTCross-Cultural Perspectives on Student Engagement and Partnership and If and How they Influence Student Belonging in a Health Professions Education Context: A Comparative Analysis Amongst Undergraduate Students in a Western versus Asian ContextIrish Network of Healthcare Educators INHED18 Aug 2025 - 31 Jul 2026
- FUNDED PROJECTStEP ProgrammeRCSI30 Sep 2024 - 29 Sep 2027
- FUNDED PROJECTStudent Selected Projects (SSP) 2024RCSI29 Apr 2024 - 28 Apr 2025
- FUNDED PROJECTCollaborative Initiative 2023/24RCSI1 Sep 2023 - 28 Feb 2025
- FUNDED PROJECTEmbedding a universal culture of student partnership across RCSI - a study to identify key enablers from a staff and student perspectiveIrish Network of Medical Educators - INMED7 Feb 2022 - 6 Feb 2023
- FUNDED PROJECTStudent Engagement and Partnership (StEP) ProjectsRCSI1 Jan 2021 - 31 Dec 2021
- FUNDED PROJECTStudent Engagement and Partnership (StEP) ProjectsIndustry1 Jan 2021 - 31 Dec 2025
- FUNDED PROJECTPlatinum(IV) Prodrugs for Precision Cancer TherapyEnterprise Ireland H2020 Support11 Oct 2019 - 10 Jul 2020
- FUNDED PROJECTSSC Research Programme 2019RCSI1 Jan 2019 - 31 Dec 2021
- FUNDED PROJECTInnovative Metallodrugs as Potent Anti-Cancer TherapeuticsEnterprise Ireland H2020 Support11 Oct 2018 - 15 Jan 2019
- FUNDED PROJECTStAR International PhD ProgrammeRCSI1 Oct 2018 - 31 Dec 2025
- FUNDED PROJECTMetallodrug Design and ActionRCSI1 Sep 2018 - 31 Aug 2027
- FUNDED PROJECTBreaking the cancer drug resistance paradigm: a novel prodrug strategy for multi-modal chemotherapeuticsScience Foundation Ireland (SFI)1 Jan 2018 - 31 Dec 2018People funded by this grant:
- Andrew K
- FUNDED PROJECTInnovative Metallodrugs as Potent Anti-Cancer Therapeutics (IMPACT)RCSI8 May 2017 - 7 May 2018
- FUNDED PROJECTIntroducing the concept of palliative care – an analysis of student perceptions of the influence and utility of a first year electiveIrish Network of Medical Educators - INMED11 Mar 2017 - 10 Mar 2018People funded by this grant:
- Laura RF
- FUNDED PROJECTInnovative Metallodrugs as Potent Anti-Cancer Therapeutics (TBC)Enterprise Ireland H2020 Support2 Nov 2016 - 23 Jul 2017
- FUNDED PROJECTMulti-Functional Metallodrug Candidates as Anti-Cancer AgentsIndustry16 Jun 2016 - 15 Dec 2017
- FUNDED PROJECTNovel Metallodrug Candidates for Therapeutic ExploitationPrivate Donor1 Apr 2014 - 1 Apr 2019
- FUNDED PROJECTAn In Vivo Study of Novel Multi-Functional Metallodrug Candidates as Anti-Cancer Agents: A Crucial Step in their CommercialisationScience Foundation Ireland (SFI)1 Jan 2013 - 31 Dec 2014
- FUNDED PROJECTExploiting Chromatin as a New Molecular Target for the Development of Novel Metallochemotherapeutics with Enhanced Selectivity and Activity Towards Cancer CellsScience Foundation Ireland (SFI)1 Sep 2011 - 31 Aug 2016People funded by this grant:
- Viktor B
- FUNDED PROJECTMetallo-Drug Design and Action (Phase 2)European Cooperation in Science & Technology (COST)1 Feb 2011 - 18 Jul 2011
- FUNDED PROJECTMetallo-Drug Design and Action (Phase 1)European Cooperation in Science & Technology (COST)1 Feb 2010 - 31 Jan 2011